24 search results for

Refine by

Content type

less

Format

less

Date

less

  • Analysis of notifications involving oral methotrexate – summary report published

    Pharmacy Board
    The analysis found that:. since 2010 there have been 28 notifications involving pharmacists and methotrexate. ... while the number of notifications involving oral…
    Date published 24 March 2021
    www.pharmacyboard.gov.au/News/2021-03-24-summary-report-published.aspx

  • Methotrexate and patient harm: an analysis of notifications involving oral methotrexate in Australia 2010 to 2019

    Australian Health Practitioner Regulation Agency
    Data was coded to identify. Key Messages. • Methotrexate is a high-risk medicine. • ... Oral cytotoxic medicines, including methotrexate, must be packed separately to a…
    Date published 22 March 2021
    Download document
    pdf document
    PDF
    199.2KB
    View as HTML

  • Tribunal reprimands pharmacist for unsafe dispensing

    Australian Health Practitioner Regulation Agency
    In January 2015, pharmacist Jennifer Barca dispensed an unsafe dose of methotrexate to a patient who subsequently died from complications of methotrexate toxicity. ... A…
    Date published 1 January 2001
    www.ahpra.gov.au/News/2021-01-22-Tribunal-reprimands-pharmacist.aspx

  • Research, strategy and policy

    Australian Health Practitioner Regulation Agency
    a review of notifications about pharmacists involving the dispensing of oral methotrexate.
    Date published 1 January 2011
    www.ahpra.gov.au/Publications/Annual-reports/Annual-Report-2020/Research-strategy.aspx

  • March 2021

    Pharmacy Board
    Methotrexate is an anti-inflammatory drug. It is also a cytotoxic used in cancer chemotherapy. ... The patient’s general practitioner prescribed methotrexate to treat a…
    Date published 1 January 2003
    www.pharmacyboard.gov.au/News/Newsletters/March-2021.aspx

  • October 2014

    Pharmacy Board
    The prescription for methotrexate was correctly dispensed by a pharmacist for packaging into a DAA for use by the patient. ... The setting out of the patient’s medication…
    Date published 31 October 2019
    www.pharmacyboard.gov.au/News/Newsletters/October-2014.aspx

  • Guidelines for dispensing of medicines

    Pharmacy Board
    unusual frequency of use (e.g. alendronate,methotrexate). 9 Guidelines for dispensing of medicines | Pharmacy Board of Australia | September 2015.
    Date published 7 May 2018
    Download document
    pdf document
    PDF
    142KB
    View as HTML

  • June 2016

    Pharmacy Board
    Methotrexate incidents. Following recent publication of research in the Medical Journal of Australia about methotrexate-related adverse events, the Board reiterates its…
    Date published 31 October 2019
    www.pharmacyboard.gov.au/News/Newsletters/June-2016.aspx

  • Professional Practice Issues

    Pharmacy Board
    Methotrexate and patient harm - an analysis of notifications involving oral methotrexate in Australia 2010 to 2019 (195 KB,PDF).
    Date published 1 January 2003
    www.pharmacyboard.gov.au/News/Professional-Practice-Issues.aspx

  • The Australian Health Practitioner Regulation Agency (Ahpra) and the ...

    Australian Health Practitioner Regulation Agency
    The Australian Health Practitioner Regulation Agency (Ahpra) and the National Boards, reporting on the. National Registration and Accreditation Scheme. Ten years of your…
    Date published 26 October 2020
    Download document
    pdf document
    PDF
    4.6MB
    View as HTML
Displaying results 1 to 10 of 24

Related searches

 
Page reviewed 28/07/2015
Home | Complaints | Freedom of information | Information Publication Scheme | Accessibility | Privacy | Glossary | Site Map | System requirements | Terms and conditions | Office locations | Contact us
© 2021 Ahpra
Ahpra ABN: 78 685 433 429